Evaluation of the expression of several markers with established prognostic factors and response to therapy in a group of Iranian childhood ALL patients has shown a positive impact for CD95 expression and a negative impact for CD20 expression in these patients. Here, FAS is linked to acute lymphoblastic leukemia.